Dice Therapeutics, Inc.
Dice Therapuetics, Inc. is a San Francisco-based biopharmaceutical company that develops medicines for chronic autoimmune and inflammatory diseases. The company was acquired by Eli Lily in August 2023.
2
Funding Rounds
$140.0m
Money raised
Overview
Dice Therapuetics, Inc. is a San Francisco-based biopharmaceutical company that develops medicines for chronic autoimmune and inflammatory diseases. The company was acquired by Eli Lily in August 2023.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| J. Ke*** Ju**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| J. Ke*** Ju**** | - | - | |
| Sh**** Te**** | - | - | - |
| Sh*** Ga**** | - | - | |
| Mi**** Do*** | - | - | - |
| Li** Bo**** | - | - | - |
| Ja** Si**** | - | - | - |
| Ri***** Sc****** | - | - | - |
| Ji* Sc*** | - | - | - |
Industries
Dice Therapeutics, Inc. is active in the following industries:
- Biotechnology
- Biology
- Technology